Close

Canaccord Genuity Maintains a 'Buy' on Vical (VICL); Q3/11 Update: A7 Data Still Expected Q2/12 Nov 2, 2011 09:35AM
Canaccord Genuity Maintains a 'Buy' on Vical (VICL); Q1/11 Update: Pipeline Programs Move Forward May 10, 2011 11:13AM
Notable Analyst Rating Changes 04/26: (OXY) (NOK) (IR) Upgraded; (MGM) (BEXP) (TXN) Downgraded Apr 26, 2011 11:00AM
UPDATE - Canaccord Genuity Initiates Coverage on Vical (VICL) with a Buy on Promising Melanoma Vaccine Candidate Apr 26, 2011 10:51AM
Canaccord Genuity Starts Vical (VICL) at Buy Apr 26, 2011 08:23AM